TRIPASS XR تري باس

 

,

4

7

3

,

4

7

4

t

,

4

7

6

R

o

m

i

d

e

p

s

i

n

,

4

6

9

t

R

o

p

i

n

i

r

o

l

e

,

1

2

5

0

t

,

1

2

5

4

–

1

2

5

5

,

1

2

5

4

t

,

1

2

6

1

,

1

9

0

6

t

R

o

p

i

v

a

c

a

i

n

e

,

1

1

7

7

t

R

o

s

i

g

l

i

t

az

o

n

e

,

1

1

2

3

,

1

1

2

4

,

1

1

2

5

fo

r

H

F

,

2

7

5

R

o

s

u

v

a

s

t

a

t

i

n

,

4

4

,

4

6

t

,

1

1

0

t

,

1

1

6

,

1

1

7

t

,

1

2

0

t

,

9

4

2

t

R

o

t

a

ri

x

(

R

V

1

)

,

1

3

6

1

R

o

t

a

T

e

q

,

1

3

6

1

R

o

t

av

i

r

u

s

v

a

c

c

i

n

e

,

1

3

5

5

R

o

t

i

g

o

t

i

n

e

,

1

2

5

1

t

,

1

2

5

4

t

,

1

2

5

5

,

1

2

6

1

–

1

2

6

2

R

o

wa

s

a

(

s

e

e

M

e

s

a

l

a

m

i

n

e

e

n

e

m

a)

R

o

z

e

r

e

m

(

s

e

e

R

a

m

e

l

t

e

o

n

)

R

P

V

(

s

e

e

R

i

l

p

i

v

i

ri

n

e

(

R

P

V)

)

R

T

V

(

s

e

e

R

i

t

o

n

av

i

r

(

R

T

V)

)

R

u

c

a

p

a

ri

b

,

4

7

0

t

R

u

fi

n

a

m

i

d

e

,

9

4

2

t

,

1

2

7

9

t

p. 2

3

1

3

p. 2

3

1

4

Ruxolitinib, 470t

RV1 (see Rotarix (RV1))

Ryzodeg, 1087

S

Sacubitril/valsartan (Entresto), 273

Safinamide, 1251t, 1264

Salicylates, 849t, 852, 1187t, 1626, 1652, 2131t

ingestion of, assessment of, 67–70

Salicylic acid, 827–828, 942t

Saline, 589–590, 589t

Salmeterol

for chronic asthma, 396–397

for COPD, 421, 421t, 422

for EIA, 401

Salsalate, 888t

Saphris (see Asenapine)

Saquinavir (SQV), 128, 942t, 1579t

Sarafem (see Fluoxetine)

Saxagliptin, 128, 1127–1128

for type 2 diabetes, 1135

Saxenda (see Liraglutide)

Scopolamine (Transderm-Scop), 468t

for end-of-life care, 89

for PONV, 478t

Second-generation triptans, 1239

Secukinumab, 842–843

Sedating drugs, 552

Sedatives, 552

Selective estrogen receptor modulators (SERMs), 2271

Selective phosphodiesterase 4 (PDE4) inhibitors, 417

Selective serotonin reuptake inhibitors (SSRIs), 1749

adverse effects, 1758–1759

for anxiety, 1859

for ASD, 1858

for bipolar depression, 1837

for critically ill patients, 1208

for depression, 1859

for depressive disorders, 1820

dosage, 1758

for hot flushes, 1036

and lithium, 1843t

for OCD, 1758

for panic disorder, 1748, 1749

for PMDD, 1025

for PTSD, 1754

and sexual response, 2261t

and sleep, 1774

Selegiline, 942t, 1251t, 1255, 1264

Selenium, 961

for prostate cancer, 2099

Senna, 2159t

Septra (see Trimethoprim-sulfamethoxazole (TMP-SMX))

SERMs (see Selective estrogen receptor modulators (SERMs))

Seroquel (see Quetiapine)

Serotonin, 1224

androgen deprivation therapy, 2097

Serotonin and norepinephrine reuptake inhibitors (SNRIs), 1748

androgen deprivation therapy, 2097

for critically ill patients, 1208

for hot flushes, 1036

for stress incontinence, 2252

Serotonin (5-HT) receptors

LSD, 1886

Sertraline (Zoloft), 1027t, 1738t, 1748, 1749

for depression, 2245

for depressive disorders, 1819t, 1820t, 1821t

for diabetes, 2226t

for OCD, 1760

for panic disorder, 1748

for prostate cancer, 2086

for SAD, 1752

and sleep, 1774

in treatment of IDH, 657

for vasomotor symptoms, 1036t

Serum aminoglycoside, 461–462

Serum immunoglobulin E antibodies, 455–456

Serum precipitins, 455–456

Serzone (see Nefazodone)

Sevelamer, 619–620

carbonate, 620t

hydrochloride, 620t

17-α hydroxyprogesterone (17-OHP), 995–996

Sildenafil, 924, 2265

and ED, 2265

Silenor (see Doxepin)

Silodosin, 2257

for BPH, 2257

Siltuximab, 469t

Silvadene (see Silver sulfadiazine cream)

Silver sulfadiazine cream (Silvadene; Aquacel Ag; ConvaTec), 863

Simeprevir, 1687–1688

Simvastatin, 46t, 55, 57, 57t, 110t, 116, 117, 117t, 120t, 125, 258

Sinecatechins, 1532

Sinemet CR (see Carbidopa–Levodopa (CR))

Singulair (see Montelukast)

Sipuleucel-T, 2095

Sirolimus, 120t, 128, 226, 722

Sitagliptin, 128, 1127–1128

for type 2 diabetes, 1135, 1139

Sivestro (see Tedizolid)

6-mercaptopurine (6-MP)

for Crohn’s disease, 529–531

for inflammatory bowel disease, 521t, 523–524

for T-cell lymphomas, 2020t

Skyla, 948

SMX (see Sulfamethoxazole (SMX))

SNRIs (see Serotonin and norepinephrine reuptake inhibitors (SNRIs))

Sodium

and children, 2140t

loss due to diarrhea, 2142

in oral electrolyte solutions, 2161t

and respiratory alkalosis, 1672

in WHO formula, 2160

Sodium bicarbonate, 643, 977

adverse effects of, 361

-carbonic acid system, 611

hyperkalemia and, 586, 587t

in metabolic acidosis, 562–563

for preventing SRMB, 515t

for salicylate toxicity, 70

for TCA toxicity, 77–78

Sodium carbonate, 1916

Sodium ferric gluconate complex, 614

Sodium–glucose transporter 2 (SGLT2) inhibitors

adverse effects of, 1130

contraindications and precautions of, 1130

for diabetes, 2225

dosage and clinical use, 1130

drug interactions, 1130

efficacy of, 1130

pharmacokinetics of, 1129–1130

Sodium oxybate, 1778–1779

Sodium polystyrene sulfonate (SPS), 586

for hyperkalemia, 587t

side effects, 586

Sodium stibogluconate, 1705t

Sodium thiosulfate, 1624t

Sodium zirconium cyclosilicate, for hyperkalemia, 586

Sofosbuvir, 1688–1689

Solifenacin, 2251–2252

Somatostatin

analogues, 502

for variceal bleeding, 513

Sonata (see Zaleplon)

Sonidegib, 470t

Sorafenib (Nexavar), 470t, 1990

Sorbitol, 67, 2156t

Sordarins, 1626

Sotalol

for AF, 316–317

and QTc, 327

for tachycardia, 1802

Spectinomycin, 1508

Spectracef (see Cefditoren)

Spectrobid (see Bacampicillin)

Spiriva Respimat, for asthma, 399

Spironolactone (Antiandrogen), 543, 546, 580–581, 2261t

for acne, 829

for hirsutism, 1012

for hypertension, 140, 157

for polycystic ovary syndrome, 1012t

Sprycel (see Dasatinib)

SPS (see Sodium polystyrene sulfonate (SPS))

SQV (see Saquinavir)

S

S

R

I

s

(

s

e

e

S

e

l

e

c

t

i

v

e

s

e

r

o

t

o

n

i

n

r

e

u

p

t

a

k

e

i

n

h

i

b

i

t

o

r

s

(

S

S

R

I

s

)

)

S

S

Z

(

s

e

e

S

u

l

fa

s

a

l

azi

n

e

(

S

S

Z)

)

S

t

a

r

c

h

,

1

6

2

7

S

t

a

t

i

n

s

,

3

7

3

S

t

av

u

d

i

n

e

(

d

4

T

)

,

fo

r

H

I

V,

9

9

6

,

1

5

7

7

t

S

t

e

r

o

i

d

s

fo

r

s

e

p

t

ic

s

h

o

c

k

,

3

7

2

S